Previous studies in both WT mice, and in CD200R-/- mice, had implied a role for both GR-1+CD11b+ (myeloid-derived suppressor cells, MDSCs) and CD8+ T cells in host resistance to EMT6 tumor cell growth in this model [2–5]. The gene discussed is CD8A; the disease is neoplasm.